| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-06 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-05 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |